KalVista Pharmaceuticals Inc Stock News

The Zacks Analyst Blog Highlights: Calavo Growers, Darling Ingredients, The Simply Good Foods Company, KalVista Pharmaceuticals and CareDx

The Zacks Analyst Blog Highlights: Calavo Growers, Darling Ingredients, The Simply Good Foods Company, KalVista Pharmaceuticals and CareDx

Here are five defensive stocks that can shield your portfolio from China's coronavirus that intimidates to weigh on the stock market.

Here are five defensive stocks that can shield your portfolio from China's coronavirus that intimidates to weigh on the stock market.

BioLineRx (BLRX) closes patient recruitment in the triple combination arm of the phase IIa COMBAT/KEYNOTE-202 study on Motixafortide to treat second-line metastatic pancreatic cancer.

As of late, it has definitely been a great time to be an investor in KalVista Pharmaceuticals.

Prospects Appear Bright for Small Drug Industry in 2020

Successful innovation resulting in new drug approvals, important advances in clinical studies, frequent collaborations and M&A activity keep small drugmakers afloat in a competitive market.

The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...

We can judge whether KalVista Pharmaceuticals, Inc. (NASDAQ:KALV) is a good investment right now by following the lead of some of the best investors in the world and piggybacking their ideas. There's

As of late, it has definitely been a great time to be an investor in KalVista Pharmaceuticals, Inc. (KALV).

If you're interested in KalVista Pharmaceuticals, Inc. (NASDAQ:KALV), then you might want to consider its beta (a...